Cover Image

The correlation between liver fibrosis and the 10‐year estimated risk of cardiovascular disease in adults with metabolic‐associated fatty liver disease: A cross‐sectional study in Vietnam

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Hai Nguyen Ngoc Dang, Thang Viet Luong, Toan Thanh Tran, Tien Anh Hoang
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Health Science Reports
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research
by: Yu‐Ming Cheng, et al.
Published: (2024)

Dietary characteristics associated with the risk of non‐alcoholic fatty liver disease and metabolic dysfunction‐associated steatotic liver disease in non‐obese Japanese participants: A cross‐sectional study
by: Hirokazu Taniguchi, et al.
Published: (2024)

LIVERSTAT for risk stratification for patients with metabolic dysfunction‐associated fatty liver disease
by: Yong Wen Leow, et al.
Published: (2024)

Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction‐associated steatotic liver disease
by: Nobuharu Tamaki, et al.
Published: (2024)

Association of liver fibrosis progression with non–liver‐related mortality in metabolic dysfunction‐associated steatotic liver disease
by: Toshifumi Tada, et al.
Published: (2025)

Lipoprotein(a) in Vietnamese Cardiologists: Findings From a Pilot Study at the Vietnam Atherosclerosis Society Congress
by: Thanh Huong Truong, et al.
Published: (2025)

Molecular pathogenesis of metabolic dysfunction‐associated steatotic liver disease, steatohepatitis, hepatic fibrosis and liver cirrhosis
by: Takashi Saito, et al.
Published: (2024)

Obstructive sleep apnea and cardiovascular disease in individuals with metabolic dysfunction‐associated fatty liver disease: A prospective cohort study
by: Haizhen Chen, et al.
Published: (2026)

The associations between fibrosis changes and liver‐related events in patients with metabolic dysfunction‐associated steatotic liver disease
by: Hye Won Lee, et al.
Published: (2024)

Thy‐1 restricts steatosis and liver fibrosis in steatotic liver disease
by: Valentin Blank, et al.
Published: (2024)

Prevalence and predictors of non‐alcoholic fatty liver disease (NAFLD) and metabolic dysfunction‐associated fatty liver disease (MAFLD) in Indian women with polycystic ovarian syndrome
by: Aditi Rathi, et al.
Published: (2025)

The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults
by: Brandon J. Perumpail, et al.
Published: (2024)

Increased risk of osteoporosis in lean/normal weight metabolic dysfunction‐associated fatty liver disease patients
by: Shao‐Wen Wang, et al.
Published: (2026)

Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus
by: Xinyu Han, et al.
Published: (2024)

Validation of serum non‐invasive tests of liver fibrosis as prognostic markers of clinical outcomes in people with fatty liver disease in Australia
by: Karl Vaz, et al.
Published: (2024)

Letter to “Prevalence and predictors of non‐alcoholic fatty liver disease ( NAFLD ) and metabolic dysfunction‐associated fatty liver disease ( MAFLD ) in Indian women with polycystic ovarian syndrome”
by: Francis de Zegher, et al.
Published: (2025)

Non‐linear relationship between liver fibrosis and femoral neck bone mineral density in metabolic dysfunction‐associated fatty liver disease patients with type 2 diabetes mellitus
by: Jie Tao, et al.
Published: (2025)

Prevalence and risk factors of metabolic dysfunction‐associated steatotic liver disease in south Central Uganda: A cross‐sectional survey
by: Rocio Enriquez, et al.
Published: (2024)

Helicobacter pylori and metabolic syndrome‐related adipokines in nonalcoholic fatty liver disease pathophysiology
by: J Kountouras, et al.
Published: (2024)

Gut microbiota dysbiosis links chronic apical periodontitis to liver fibrosis in nonalcoholic fatty liver disease: Insights from a mouse model
by: Guowu Gan, et al.
Published: (2024)

Risk of cardiovascular disease in elderly subjects with obesity and liver fibrosis and the potential benefit of statin treatment
by: Willy B. Theel, et al.
Published: (2024)

Coastal biological resources of Vietnam: research and management
by: Dang, Ngoc Thanh
Published: (1995)

Editorial: Paradox of liver fat content in the spectrum of non‐alcoholic fatty liver disease
by: Sung Won Chung, et al.
Published: (2024)

Erythropoietin hyporesponsiveness in non‐alcoholic fatty liver disease
by: Huixi Zou, et al.
Published: (2024)

Metabolic dysfunction‐associated fatty liver disease and risks of incident coronary artery disease and cerebrovascular disease: LIFE Study
by: Yurina Akeno, et al.
Published: (2025)

Association of metabolic dysfunction‐associated fatty liver disease with gallstone development: A longitudinal study
by: Masahiro Sogabe, et al.
Published: (2024)

Assessment of metabolic dysfunction‐associated steatotic liver disease in patients with hidradenitis suppurativa: A cross‐sectional study
by: N. Omari, et al.
Published: (2024)

Dodecanedioic acid prevents and reverses metabolic‐associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet‐induced obesity
by: Giulia Angelini, et al.
Published: (2024)

GDF11: An emerging therapeutic target for liver diseases and fibrosis
by: Pardis Habibi, et al.
Published: (2024)

Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease
by: Nobuharu Tamaki, et al.
Published: (2024)

Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction‐associated steatotic liver disease
by: Richie Manikat, et al.
Published: (2024)

A Hyper-Transformer model for Controllable Pareto Front Learning with Split Feasibility Constraints
by: Tuan, Tran Anh, et al.
Published: (2024)

Biodiversity risk and firm performance: Evidence from US firms
by: Thang Ngoc Bach, et al.
Published: (2024)

Associations of serum carotenoids with cardiovascular disease mortality among patients with metabolic dysfunction‐associated steatotic liver disease
by: Qian‐Qian Wang, et al.
Published: (2025)

Potential mediation effect of insulin resistance on the association between iron metabolism indicators and non‐alcoholic fatty liver disease
by: Xin Zhang, et al.
Published: (2024)

Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
by: Hannes Hagström, et al.
Published: (2024)

Associations between cuprotosis‐related genes and the spectrum of metabolic dysfunction‐associated fatty liver disease: An exploratory study
by: Hai‐Yang Yuan, et al.
Published: (2024)

Hepatic Mac2‐BP expression depends on liver fibrosis and inflammation due to fat accumulation in patients with metabolic dysfunction‐associated steatotic liver disease
by: Haruki Uojima, et al.
Published: (2024)

Knowledge and attitudes about dementia among nursing students in Vietnam: a cross‐sectional study
by: Dung Thi My Pham, et al.
Published: (2025)

Evaluation of tri‐ponderal mass index in predicting metabolic associated fatty liver disease in obese children
by: Yavuz Özer, et al.
Published: (2025)